Cargando…

Effects of Epeleuton, a Novel Synthetic Second‐Generation n‐3 Fatty Acid, on Non‐Alcoholic Fatty Liver Disease, Triglycerides, Glycemic Control, and Cardiometabolic and Inflammatory Markers

BACKGROUND: Epeleuton is 15‐hydroxy eicosapentaenoic acid ethyl ester, a second‐generation synthetic n‐3 fatty acid derivative of eicosapentaenoic acid. The primary objective was to assess the effect of epeleuton on markers of nonalcoholic fatty liver disease (NAFLD) with post hoc analyses of cardio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Climax, John, Newsome, Philip N., Hamza, Moayed, Weissbach, Markus, Coughlan, David, Sattar, Naveed, McGuire, Darren K., Bhatt, Deepak L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660824/ https://www.ncbi.nlm.nih.gov/pubmed/32779505 http://dx.doi.org/10.1161/JAHA.119.016334

Ejemplares similares

P1483: EPELEUTON, A NOVEL SYNTHETIC SECOND GENERATION W-3 FATTY ACID, PROTECTS HUMANIZED SICKLE CELL MICE AGAINST HYPOXIA/REOXYGENATION ORGAN DAMAGE
por: Federti, E., et al.
Publicado: (2022)

P1439: EPELEUTON, A NOVEL SYNTHETIC Ω-3 FATTY ACID, REDUCES ENDOTHELIAL ADHESION OF RED BLOOD CELLS FROM SICKLE CELL DISEASE PATIENTS UNDER PHYSIOLOGICAL FLOW CONDITIONS
por: Hamza, Moayed, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease
por: Sattar, Naveed, et al.
Publicado: (2014)

Uncommon Fatty Acids and Cardiometabolic Health
por: Li, Kelei, et al.
Publicado: (2018)

Triglyceride cycling enables modification of stored fatty acids
por: Wunderling, Klaus, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease, Liver Fibrosis, and Cardiometabolic Risk Factors in Adolescence: A Cross-Sectional Study of 1874 General Population Adolescents
por: Lawlor, Debbie A., et al.
Publicado: (2014)

MicroRNA-124 Regulates Fatty Acid and Triglyceride Homeostasis
por: Shaw, Tyler A., et al.
Publicado: (2018)

Triglycerides of medium-chain fatty acids: a concise review
por: Jadhav, Harsh B., et al.
Publicado: (2022)

Identifying Patients with Nonalcoholic Fatty Liver Disease in Primary Care: How and for What Benefit?
por: Schreiner, Andrew D., et al.
Publicado: (2023)

Obesity in Children and Future Cardiometabolic Risk: Are blood tests necessary?
por: Logue, Jennifer, et al.
Publicado: (2010)

Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
por: Kawano, Yuki, et al.
Publicado: (2013)

Cardiometabolic characterization in metabolic dysfunction–associated fatty liver disease
por: Perdomo, Carolina M., et al.
Publicado: (2022)

Sedentary Behavior Is Not Associated with Cardiometabolic Risk in Adults with Abdominal Obesity
por: McGuire, K. Ashlee, et al.
Publicado: (2011)

Polyunsaturated Fatty Acids and Glycemic Control in Type 2 Diabetes
por: Telle-Hansen, Vibeke H., et al.
Publicado: (2019)

Comparison of the Utility of Total Plasma Fatty Acids Versus those in Cholesteryl Ester, Phospholipid, and Triglyceride as Biomarkers of Fatty Acid Intake
por: Furtado, Jeremy D., et al.
Publicado: (2019)

Interference of flavonoids with enzymatic assays for the determination of free fatty acid and triglyceride levels
por: Hoek-van den Hil, Elise F., et al.
Publicado: (2011)

Pro- and Antioxidative Effect of α-Tocopherol on Edible Oils, Triglycerides and Fatty Acids
por: Jerzykiewicz, Maria, et al.
Publicado: (2013)

Systemic Free Fatty Acid Disposal Into Very Low-Density Lipoprotein Triglycerides
por: Koutsari, Christina, et al.
Publicado: (2013)

Discordant hepatic fatty acid oxidation and triglyceride hydrolysis leads to liver disease
por: Selen, Ebru S., et al.
Publicado: (2021)

Fasting, non-fasting and postprandial triglycerides for screening cardiometabolic risk
por: Keirns, Bryant H., et al.
Publicado: (2021)

School Nutrition Program; Prevention of Obesity and Fatty Liver in Children
por: Ardalan, Gelayol, et al.
Publicado: (2014)

Pathogenesis of non-alcoholic fatty liver disease
por: Dowman, J. K., et al.
Publicado: (2010)

Elevated levels of alanine transaminase and triglycerides within normal limits are associated with fatty liver
por: TOMIZAWA, MINORU, et al.
Publicado: (2014)

POSTPRANDIAL TRIGLYCERIDES AND ADIPOSE TISSUE STORAGE OF DIETARY FATTY ACIDS: IMPACT OF MENOPAUSE AND ESTRADIOL
por: Bessesen, DH, et al.
Publicado: (2014)

Regiospecific Analysis of Fatty Acids and Calculation of Triglyceride Molecular Species in Marine Fish Oils
por: Zhang, Huijun, et al.
Publicado: (2018)

Triglycerides Promote Lipid Homeostasis during Hypoxic Stress by Balancing Fatty Acid Saturation
por: Ackerman, Daniel, et al.
Publicado: (2018)

High-Yield Production of Fatty Nitriles by One-Step Vapor-Phase Thermocatalysis of Triglycerides
por: Shirazi, Yaser, et al.
Publicado: (2017)

Free fatty acids and triglyceride change in the gallbladder bile of gallstone patients with pancreaticobiliary reflux
por: Xiang, Yukai, et al.
Publicado: (2021)

Triglyceride-derived fatty acids reduce autophagy in a model of retinal angiomatous proliferation
por: Heckel, Emilie, et al.
Publicado: (2022)

Protocol for measuring intrahepatic triglyceride content in adults with non-alcohol fatty liver disease
por: Ezpeleta, Mark, et al.
Publicado: (2023)

Ingestion of triglycerides containing medium- and long-chain fatty acids can increase metabolism of ingested long-chain triglycerides in overweight persons
por: Nosaka, Naohisa, et al.
Publicado: (2023)

Characterization of Retail Conventional, Organic, and Grass Full-Fat Butters by Their Fat Contents, Free Fatty Acid Contents, and Triglyceride and Fatty Acid Profiling
por: Pustjens, Annemieke M., et al.
Publicado: (2017)

The Triglyceride/HDL Ratio and Triglyceride Glucose Index as Predictors of Glycemic Control in Patients with Diabetes Mellitus Type 2
por: Babic, Nermina, et al.
Publicado: (2019)

Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases
por: Han, Eugene, et al.
Publicado: (2017)

Oxidative stress and cardiometabolic biomarkers in patients with non-alcoholic fatty liver disease
por: Klisic, Aleksandra, et al.
Publicado: (2021)

Fatty Pancreas and Cardiometabolic Risk: Response of Ectopic Fat to Lifestyle and Surgical Interventions
por: Leiu, Kok Hong, et al.
Publicado: (2022)

Diagnostic ability using fatty liver and metabolic markers for metabolic‐associated fatty liver disease stratified by metabolic/glycemic abnormalities
por: Okada, Akira, et al.
Publicado: (2022)

Characterization of fatty acid modifying enzyme activity in staphylococcal mastitis isolates and other bacteria
por: Lu, Thea, et al.
Publicado: (2012)

Nonalcoholic fatty liver disease in relation to the remission and progression along the glycemic continuum
por: Xin, Zhuojun, et al.
Publicado: (2022)

Paradoxical Coupling of Triglyceride Synthesis and Fatty Acid Oxidation in Skeletal Muscle Overexpressing DGAT1
por: Liu, Li, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_q8kdurmjfad50s27vpi3md4b8r